ARTICLE | Clinical News
ATI-5923: Phase II data
November 24, 2008 8:00 AM UTC
In an open-label Phase II trial, ATI-5923 produced stable control of anticoagulation for a mean TTR of 72%. Stable control was achieved for a mean TTR of 59% in patients who had previously received wa...